Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Invesco Small Cap Discovery A (VASCX)

11.53
Net Asset Value
+0.26%
1 Day
+10.65%
Year-to-Date
Overall Morningstar Rating
Small growth
Style or Category
5.5
Sales Expenses
1.32%
Expense Ratio
Below Average
Morningstar Risk Rating™
Investment Objective The investment seeks capital appreciation. The fund invests, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of small-capitalization companies, and in other instruments that have economic characteristics similar to such securities. It invests primarily in equity securities of small-capitalization companies that the fund's investment adviser believes have above-average potential for capital appreciation. The fund may invest up to 25% of its net assets in securities of foreign issuers.

Performance

1 month-0.35% 3 years+19.38%
3 months+4.25% 5 years+16.30%
1 year+20.48% Since inception+5.18%
Data through --

Peer Comparisonvs. Small growth

 VASCXCategory
Performance 5-yr return+16.30%+17.65%
Expense ratio1.32%1.37%
Risk 5 year sharpe ratio1.091.05
Net assets$813.0M$835.3M
Average market cap$3.2B$2.9B
Average P/E29.428.2
Portfolio turnover----

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyInvesco
Fund manager & tenureMatthew Hart / 14 Years
Minimal initial investment$1,000.00
Minimum IRA investment$250.00

Holdings

U.S. stock93.32%
International stock3.54%
Cash3.13%
Fixed income0.00%
Other0.00%
Top 5 Sectors
Portfolio weighting
Healthcare 16.75%
Consumer goods 15.14%
Industrial materials 13.97%
Hardware 11.26%
Energy 8.25%
Top 10 Holdings
Portfolio weighting
ACHC Acadia Healthcare Company Inc1.87%
THRM Gentherm Inc1.67%
IPXL Impax Laboratories Inc1.64%
CNK Cinemark Holdings Inc1.62%
CAVM Cavium Inc1.62%
BC Brunswick Corp1.60%
PRXL PAREXEL International Corp1.57%
PCRX Pacira Pharmaceuticals Inc1.54%
TMH TeamHealth Holdings Inc1.51%
QRVO Qorvo Inc1.46%